OAM
HARP

Oxford Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Oxford Asset Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,007
Closed -$297K – 1468
2019
Q4 		$297K Buy
+2,007
New +$304K 0.01% 1441

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Oxford Asset Management's HARP Position: Q1 2020 in Review

Oxford Asset Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2020, closing a stake of 2,007 shares — an estimated $297K sold.

Oxford Asset Management first reported a position in HARP in Q4 2019 and held it in 1 quarter. The position peaked at $297K in Q4 2019. 53 funds tracked by Wall St. Rank hold HARP as of Q1 2020.

  • Oxford Asset Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 2,007 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $297K.
  • Oxford Asset Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Oxford Asset Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $297K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.